A small synthetic cripto blocking peptide improves neural induction, dopaminergic differentiation, and functional integration of mouse embryonic stem cells in a rat model of Parkinson's disease

Stem Cells

Volumn 28, Issue 8, 2010, Pages 1326-1337

  Lonardo, Enza ^a   Parish, Clare L ^b,c   Ponticelli, Salvatore ^a   Marasco, Daniela ^d   Ribeiro, Diogo ^b   Ruvo, Menotti ^e   De Falco, Sandro ^a   Arenas, Ernest ^b   Minchiotti, Gabriella ^a  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e CNR   (Italy)

Author keywords

Cell transplantation; Cellular therapy; Embryonic stem cells; Neural differentiation; Parkinson's disease

Indexed keywords

ACTIVIN RECEPTOR 1; GLYCOSYLPHOSPHATIDYLINOSITOL; PEPTIDE; PEPTIDE LIBRARY; TETRAMER; TRIPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; COMBINATORIAL LIBRARY; CONTROLLED STUDY; CONVALESCENCE; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EMBRYO; EMBRYO CELL; EMBRYONIC STEM CELL; ENGRAFTMENT; GENETIC MANIPULATION; GENETICS; IN VITRO STUDY; IN VIVO STUDY; INTEGRATION; MESENCEPHALON; MOUSE; MOUSE EMBRYO; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROECTODERM; NONHUMAN; PARKINSON DISEASE; RAT; SIGNAL TRANSDUCTION;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; EPIDERMAL GROWTH FACTOR; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASM PROTEINS; NEURONS; OLIGOPEPTIDES; PARKINSON DISEASE; PROTEIN BINDING; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION;

RATTUS;

EID: 77955786933     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.458     Document Type: Article

References (53)

1. Strizzi L, Bianco C, Normanno N et al. Cripto-1: A multifunctional modulator during embryogenesis and oncogenesis. Oncogene 2005;24:5731-5741. (Pubitemid 43086133)
2. Minchiotti G. Nodal-dependant Cripto signaling in ES cells: From stem cells to tumor biology. Oncogene 2005;24:5668-5675.
3. Cheng SK, Olale F, Bennett JT et al. EGF-CFC proteins are essential coreceptors for the TGF-beta signals Vg1 and GDF1. Genes Dev 2003;17:31-36.
4. Reissmann E, Jornvall H, Blokzijl A et al. The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. Genes Dev 2001;15:2010-2022.
5. Schier AF. Chemokine signaling: Rules of attraction. Curr Biol 2003;13:R192-R194.
6. Massague J, Chen YG. Controlling TGF-beta signaling. Genes Dev 2000;14:627-644.
7. Gray PC, Harrison CA, Vale W. Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc Natl Acad Sci USA 2003;100:5193-5198. (Pubitemid 36542681)
8. Kelber JA, Shani G, Booker EC, Vale WW, Gray PC. Cripto is a non-competitive activin antagonist that forms analogous signaling complexes with activin and nodal. J Biol Chem 2008;283:4490-4500.
9. Gray PC, Shani G, Aung K et al. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling. Mol Cell Biol 2006;26:9268-9278.
10. Shani G, Fischer WH, Justice NJ et al. GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth. Mol Cell Biol 2008;28:666-677.
11. Shukla A, Ho Y, Liu X et al. Cripto-1 alters keratinocyte differentiation via blockade of transforming growth factor-beta1 signaling: Role in skin carcinogenesis. Mol Cancer Res 2008;6:509-516. (Pubitemid 351416541)
12. Parisi S, D'Andrea D, Lago CT et al. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells. J Cell Biol 2003;163:303-314. (Pubitemid 37363131)
13. Parish CL, Parisi S, Persico MG et al. Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease. Stem Cells 2005;23:471-476.
14. Sonntag KC, Simantov R, Bjorklund L et al. Context-dependent neuronal differentiation and germ layer induction of Smad4(-/-) and Cripto(-/-) embryonic stem cells. Mol Cell Neurosci 2005;28:417-429.
15. Parish CL, Arenas E. Stem-cell-based strategies for the treatment of Parkinson's disease. Neurodegener Dis 2007;4:339-347. (Pubitemid 47026190)
16. Lindvall O, Hagell P. Clinical observations after neural transplantation in Parkinson's disease. Prog Brain Res 2000;127:299-320.
17. Winkler C, Kirik D, Bjorklund A. Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci 2005;28:86-92.
18. Kriks S, Studer L. Protocols for generating ES cell-derived dopamine neurons. Adv Exp Med Biol 2009;651:101-111.
19. Koch P, Kokaia Z, Lindvall O et al. Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling. Lancet Neurol 2009;8:819-829.
20. Li JY, Christophersen NS, Hall V et al. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci Mar 2008;31:146-153.
21. Lindvall O, Kokaia Z. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci 2009;30:260-267.
22. Jonsson ME, Ono Y, Bjorklund A et al. Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis. Exp Neurol 2009;219:341-354.
23. Lindvall O, Kokaia Z. Stem cells in human neurodegenerative disorders - Time for clinical translation? J Clin Invest 2010;120:29-40.
24. Chung S, Shin BS, Hedlund E et al. Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. J Neurochem 2006;97:1467-1480.
25. Hedlund E, Pruszak J, Lardaro T et al. Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells 2008;26:1526-1536.
26. Villaescusa JC, Arenas E. Transplantable midbrain dopamine neurons: A moving target. Exp Neurol 2010;222:173-178.
27. Friling S, Andersson E, Thompson LH et al. Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc Natl Acad Sci USA 2009;106:7613-7618.
28. Sonntag KC, Pruszak J, Yoshizaki T et al. Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells 2007;25:411-418. (Pubitemid 46232796)
29. Chiba S, Lee YM, Zhou W et al. Noggin enhances dopamine neuron production from human embryonic stem cells and improves behavioral outcome after transplantation into Parkinsonian rats. Stem Cells 2008;26:2810-2820.
30. Chambers SM, Fasano CA, Papapetrou EP et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009;27:275-280.
31. Marino M, Ruvo M, De Falco S et al. Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide. Nat Biotechnol 2000;18:735-739.
32. Nagy A, Rossant J, Nagy R et al. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci USA. 1993;90:8424-8428. (Pubitemid 23277681)
33. Xu C, Liguori G, Adamson ED et al. Specific arrest of cardiogenesis in cultured embryonic stem cells lacking Cripto-1. Dev Biol 1998;196:237-247.
34. Minchiotti G, Parisi S, Persico MG. Cripto signaling in differentiating embryonic stem cells. Methods Mol Biol 2006;329:151-169.
35. Paxinos G, Watson C. The Rat Brain in Stereotaxic Co-ordinates. 3rd ed. Sydney: Academic Press, 1998.
36. Tam JP. Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci USA 1988;85:5409-5413.
37. Boheler KR, Crider DG, Tarasova Y et al. Cardiomyocytes derived from embryonic stem cells. Methods Mol Med 2005;108:417-435.
38. Smidt MP, Smits SM, Burbach JP. Homeobox gene Pitx3 and its role in the development of dopamine neurons of the substantia nigra. Cell Tissue Res 2004;318:35-43.
39. Ye W, Shimamura K, Rubenstein JL et al. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 1998;93:755-766. (Pubitemid 28257582)
40. Castelo-Branco G, Wagner J, Rodriguez FJ et al. Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, And Wnt-5a. Proc Natl Acad Sci USA 2003;100:12747-12752.
41. Barberi T, Klivenyi P, Calingasan NY et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol 2003;21:1200-1207.
42. Parish CL, Castelo-Branco G, Rawal N et al. Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J Clin Invest 2008;118:149-160.
43. Schein JC, Hunter DD, Roffler-Tarlov S. Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver. Dev Biol 1998;204:432-450. (Pubitemid 29024490)
44. Adkins HB, Bianco C, Schiffer SG et al. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J Clin Invest 2003;112:575-587.
45. Li W, Ding S. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol Sci 2010;31:36-45.
46. Ding S, Schultz PG. A role for chemistry in stem cell biology. Nat Biotechnol 2004;22:833-840.
47. Chen S, Do JT, Zhang Q et al. Self-renewal of embryonic stem cells by a small molecule. Proc Natl Acad Sci USA 2006;103:17266-17271.
48. Huangfu D, Maehr R, Guo W et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008;26:795-797. (Pubitemid 351961456)
49. Borowiak M, Maehr R, Chen S et al. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell 2009;4:348-358.
50. Schmierer B, Hill CS. TGFbeta-SMAD signal transduction: Molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007;8:970-982.
51. Inman GJ, Nicolas FJ, Callahan JF et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, And ALK7 Mol Pharmacol 2002;62:65-74.
52. Kim JH, Auerbach JM, Rodriguez-Gomez JA et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002;418:50-56.
53. Fukuda H, Takahashi J, Watanabe K et al. Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation. Stem Cells 2006;24:763-771.